Céline Gongora

Title: Céline Gongora: Innovator in Prostate Cancer Treatment

Introduction

Céline Gongora is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of prostate cancer. His innovative approach combines various active ingredients to enhance treatment efficacy for patients suffering from this disease.

Latest Patents

Céline Gongora holds 1 patent for his invention titled "Association of actives for treating prostate cancer." This invention focuses on a pharmaceutical combination that includes an inhibitor of the androgen receptor signaling pathway and a p38 inhibitor. It is designed for use in treating prostate cancer in individuals whose prostate tumor cells express the AR-V7 variant androgen receptor protein. The invention also aims to prevent resistance in patients undergoing treatment with androgen receptor inhibitors. Furthermore, it encompasses a pharmaceutical composition that includes enzalutamide, abiraterone, or apalutamide, along with a selected p38 inhibitor and at least one pharmaceutically acceptable excipient.

Career Highlights

Throughout his career, Céline Gongora has worked with esteemed institutions such as the Institut Régional Du Cancer De Montpellier and the Institut National De La Santé Et De La Recherche Médicale. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.

Collaborations

Céline has collaborated with various professionals, including Diego Tosi, to advance his research and innovations in the pharmaceutical sector.

Conclusion

Céline Gongora's contributions to prostate cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in the field of oncology.